ID   PC3B1
AC   CVCL_D689
SY   PC3-B1
DR   BTO; BTO_0005121
DR   cancercelllines; CVCL_D689
DR   Wikidata; Q54938580
RX   PubMed=19491258;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
RX   PubMed=19491258; DOI=10.1158/0008-5472.CAN-09-0354; PMCID=PMC2697270;
RA   Ports M.O., Nagle R.B., Pond G.D., Cress A.E.;
RT   "Extracellular engagement of alpha6 integrin inhibited urokinase-type
RT   plasminogen activator-mediated cleavage and delayed human prostate
RT   bone metastasis.";
RL   Cancer Res. 69:5007-5014(2009).
//